[ad_1]
It has been claimed that the inadequacy of test production and distribution at the start of the new type of coronavirus (Kovid-19) epidemic in China and erroneous tests produced with privileges provided behind closed doors to incompetent companies prevented the virus from being noticed. .
According to a news study prepared by the Associated Press (AP) news agency through face-to-face interviews with more than 40 doctors, health officials, experts and industry practitioners, officials from the Chinese Center for Disease Control and Prevention (CDC ) only tested 3 Shanghai-based companies. privilege of producing and sharing virus information only with these companies, resulting in insufficient tests being released.
Therefore, thousands of people who went to health centers with disease reports in January in the city of Wuhan, where the outbreak occurred, had to wait in line for hours to be tested.
Furthermore, as tests produced by incompetent companies are insufficient to diagnose the virus, it has mainly led to false negative results.
class = “cf”>
Insufficient testing quantity and effectiveness prevented the virus from detecting the rate of spread of the virus in the critical first months of the outbreak and taking effective measures against it.
3 PRESENTATION OF THE COMPANY
CDC granted the privilege of developing and distributing test kits to previously unknown companies GeneoDx Biotech, Huirui Biotechnology and BioGerm Medical Technology in Shanghai. The agreements were concluded through closed-door negotiations, not through open tenders. The companies paid 1 million yuan (about $ 150,000) for access to virus information and manufacturing concessions.
Meanwhile, both the CDC and its National Health Commission (NHC) have tried to prevent other organizations and scientists from testing and producing test kits. The NHC allowed virus samples from Wuhan hospitals to be sent only to their designated laboratories. On the other hand, it made the legal and medical requirements for testing difficult and encouraged the use of test kits produced by only 3 companies.
CAN BE DETERMINED 1 OUT OF EVERY 19 VIRUS VECTORS
class = “cf”>
No new cases were detected in the city between January 5th and 17th due to the limited and insufficient number of tests. This prevented the first steps to stop the spread of the virus. Although both the public and the authorities got the wrong impression of the virus, effective measures such as curfews, assembly bans and transport restrictions could not be taken.
In the study published in the journal “Nature” on May 4, it was predicted that if the outbreak occurred two weeks before the Wuhan city quarantine on January 23, the number of cases worldwide could fall by 86 percent. .
When the tests provided by the Shanghai companies began to be implemented, they often produced uncertain or false negative results.
According to Imperial College London, only 1 in 19 people carrying the virus in Wuhan are expected to be detected by January 31 due to the limited number of incorrect testing practices.
Covid-19, which appeared in Wuhan, China in December 2019, has spread to more than 200 countries and regions. As the number of cases worldwide approached 65 million, more than 1.5 million people have died from the virus.
THIS VIDEO MAY BE INTERESTED
.
[ad_2]
Source link
